The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGSS.L Regulatory News (GSS)

  • There is currently no data for GSS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Genesis Emerging Markets Fund

1 Dec 2020 08:00

RNS Number : 9865G
Genesis Emerging Markets Fund Ld
01 December 2020
 

 

London, UK, 1 December 2020

Edison issues review on Genesis Emerging Markets Fund (GSS)

Genesis Emerging Markets Fund (GSS) remains broadly diversified across a range of sectors and countries and is well positioned to take advantage of a further broad-based recovery in emerging markets (EM). In addition, the management team is always on the hunt for refreshing investment themes. EM equities are climbing rapidly back to pre-COVID-19 heights, to the level seen in the 11-year equity bull market, before it corrected sharply in response to the coronavirus pandemic. Stock markets have a history of survival and full recovery from major systemic shocks, and the long-term outlook for EM remains positive.

 

The chart above illustrates that EM might have bottomed out and so might present a good entry point for investors. GSS's portfolio of 101 holdings (at 31 October 2020) is diversified geographically and by sectors, with thematic exposures, including digital wallets, which is a theme introduced in this report. Karen Roydon, a GSS portfolio manager, who spoke to us recently, highlights that not all digital wallets are created equal. While GSS expects the theme to grow further within the portfolio and contribute positively to the fund's future performance, the team studies

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Victoria Chernykh, +44 (0)20 3077 5700

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAKKKBKABDDFDN
Date   Source Headline
4th Oct 20213:46 pmRNSChange of Name
4th Oct 202111:17 amRNSNet Asset Value(s)
1st Oct 202112:27 pmRNSResult of EGM
1st Oct 202112:26 pmRNSNet Asset Value(s)
30th Sep 20215:35 pmRNSTotal Voting Rights
30th Sep 202112:46 pmRNSNet Asset Value(s)
29th Sep 202110:39 amRNSNet Asset Value(s)
28th Sep 202110:59 amRNSNet Asset Value(s)
27th Sep 202111:16 amRNSNet Asset Value(s)
24th Sep 202110:58 amRNSNet Asset Value(s)
23rd Sep 202110:50 amRNSNet Asset Value(s)
22nd Sep 202111:31 amRNSNet Asset Value(s)
21st Sep 202110:37 amRNSNet Asset Value(s)
20th Sep 20215:08 pmRNSAvailability of monthly factsheet
20th Sep 202111:09 amRNSNet Asset Value(s)
17th Sep 202110:46 amRNSNet Asset Value(s)
16th Sep 202110:23 amRNSNet Asset Value(s)
15th Sep 202110:44 amRNSNet Asset Value(s)
14th Sep 202111:51 amRNSNet Asset Value(s)
13th Sep 202110:53 amRNSNet Asset Value(s)
10th Sep 202111:06 amRNSNet Asset Value(s)
9th Sep 202110:34 amRNSNet Asset Value(s)
8th Sep 202110:43 amRNSNet Asset Value(s)
7th Sep 202110:34 amRNSNet Asset Value(s)
3rd Sep 202111:16 amRNSNet Asset Value(s)
2nd Sep 202110:38 amRNSNet Asset Value(s)
1st Sep 202111:41 amRNSNet Asset Value(s)
31st Aug 20216:05 pmRNSTotal Voting Rights
31st Aug 202110:57 amRNSNet Asset Value(s)
27th Aug 202111:50 amRNSNet Asset Value(s)
26th Aug 202111:41 amRNSNet Asset Value(s)
25th Aug 202111:23 amRNSNet Asset Value(s)
24th Aug 202110:42 amRNSNet Asset Value(s)
23rd Aug 202110:44 amRNSNet Asset Value(s)
20th Aug 202111:10 amRNSNet Asset Value(s)
19th Aug 202110:38 amRNSNet Asset Value(s)
18th Aug 202111:21 amRNSNet Asset Value(s)
17th Aug 202110:52 amRNSNet Asset Value(s)
16th Aug 20213:13 pmRNSAvailability of monthly factsheet
16th Aug 202110:39 amRNSNet Asset Value(s)
13th Aug 202110:44 amRNSNet Asset Value(s)
12th Aug 202111:13 amRNSNet Asset Value(s)
11th Aug 202110:39 amRNSNet Asset Value(s)
10th Aug 202110:40 amRNSNet Asset Value(s)
10th Aug 202110:20 amRNSDirector/PDMR Shareholding
9th Aug 202110:50 amRNSNet Asset Value(s)
6th Aug 202110:35 amRNSNet Asset Value(s)
5th Aug 20215:00 pmRNSUpdate on Change of Management Arrangements
5th Aug 202110:48 amRNSNet Asset Value(s)
4th Aug 202110:49 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.